Related Experiment Videos
Stevens-Johnson syndrome after erythromycin therapy while deployed at sea
1Naval Hospital Branch Medical Clinic, Naval Air Station, Jacksonville, FL 32214-5000, USA.
Military Medicine
|August 25, 2000
Summary
Stevens-Johnson syndrome is a severe drug reaction. This case highlights erythromycin as a trigger in a deployed military setting, emphasizing the need for vigilance in diagnosing this serious cutaneous reaction.
Area of Science:
- Dermatology
- Pharmacology
- Infectious Diseases
Background:
- Stevens-Johnson syndrome (SJS) is a severe mucocutaneous reaction, often drug-induced.
- It represents a spectrum of erythema multiforme, ranging from mild to life-threatening.
- Distinguishing SJS from toxic epidermal necrolysis (TEN) is based on the percentage of body surface area affected.
Observation:
- The case involves a service member aboard an aircraft carrier in the Persian Gulf.
- The patient developed Stevens-Johnson syndrome following treatment with erythromycin.
- This highlights a potential adverse drug reaction in a unique operational environment.
Findings:
- Erythromycin was identified as the likely trigger for Stevens-Johnson syndrome in this case.
- Common triggers for SJS include infections (herpes simplex, Mycoplasma) and drug reactions.
- This case adds to the understanding of drug-induced SJS in specific populations.
Implications:
- Awareness of SJS and its triggers, including common antibiotics like erythromycin, is crucial for clinicians.
- Prompt recognition and management are vital for improving patient outcomes in severe cutaneous reactions.
- This case underscores the importance of considering drug reactions in deployed settings where diagnostic resources may be limited.